Name: Bacteroides fragilis EN-2
Creator: BacDive
License: http://creativecommons.org/licenses/by-nc/4.0/

Strain identifier

BacDive ID: 1585

Type strain:

Species: Bacteroides fragilis

Strain Designation: EN-2, Onslow

Culture col. no.: DSM 2151, ATCC 25285, JCM 11019, NCTC 9343, CCUG 4856, CCM 4712, VPI 2553, CIP 77.16, KCTC 3688, KCTC 5013, LMG 10263, LMG 11261, NCDO 2217

Strain history: CIP <- 1977, M. Sebald, Inst. Pasteur, Paris, France <- NCTC <- Saint Bartholomew Hosp., London, UK <- 1955, L.P. Garrod : strain Onslow

NCBI tax ID(s): 272559 (strain), 817 (species)

SI-ID 389404

JCM 11019, LMG 10263, ATCC 25285, CCUG 4856, DSM 2151, LMG 11261, NCDO 2217, NCTC 9343, CCM 4712, CCUG 38583, CIP 77.16, KCTC 2609, KCTC 5013, KCTC 3688, BCRC 10620, CCRC 10620, ACM 1145, ACM 4768, ACM 5196, CNCTC 5632, VTT E-022248

Other strains from Bacteroides fragilis

B. fragilis LRA 048 07 85, CCUG 25931, DSM ...
B. fragilis mprl 1839, MPRL 1839/MH3, DSM 9668
B. fragilis mprl 1842, DSM 9669
B. fragilis mprl 1843, DSM 9671
B. fragilis HSP 40, CIP 104785, ATCC 51477, ...
B. fragilis CIP pIP417
B. fragilis CIP pIP419
B. fragilis CIP pIP421
B. fragilis 638R, CIP 108284
B. fragilis BF8, CIP 108277
B. fragilis 10010, CIP 105891, ATCC 43858
B. fragilis CIP 105892, ATCC 43859
B. fragilis CCUG 34384
B. fragilis CCUG 34457
B. fragilis CCUG 35615
B. fragilis CCUG 35671
B. fragilis CCUG 36902
B. fragilis CCUG 36926
B. fragilis CCUG 37758
B. fragilis CCUG 49424
B. fragilis CCUG 54315
B. fragilis COR2-248-WT-1, DSM 103087
B. fragilis 638R/pIP417(nimA), DSM 103646
B. fragilis BF8, DSM 103647
B. fragilis JCM 17585
B. fragilis JCM 17586
B. fragilis JCM 17587

Section

Bacteroides fragilis EN-2 is an anaerobe, mesophilic, Gram-negative human pathogen that was isolated from appendix abscess.

Gram-negative
anaerobe
human pathogen
mesophilic
16S sequence
Bacteria
genome sequence

Information on the name and the taxonomic classification. Name and taxonomic classification

	Last LPSN update	14-12-2023 (DD-MM-YYYY)
	Domain	"Bacteria"
	Phylum	*Bacteroidota*
	Class	*Bacteroidia*
	Order	*Bacteroidales*
	Family	*Bacteroidaceae*
	Genus	*Bacteroides*
	Species	**Bacteroides fragilis**
	Full Scientific Name (LPSN)	Bacteroides fragilis (Veillon and Zuber 1898) Castellani and Chalmers 1919 (Approved Lists 1980)

Synonym

"Bacillus fragilis"

Information on morphological and physiological properties Morphology

[Ref.: #119445]	Gram stain	negative
[Ref.: #69480]	Gram stain	negative Confidence in %99.999

[Ref.: #119445]	Cell shape	rod-shaped

[Ref.: #119445]	Motility	no

[Ref.: #979]	Type of hemolysis	alpha
[Ref.: #979]	Hemolysis ability	1
[Ref.: #979]	Incubation period	1-2 days

[Ref.: #119445]	Hemolysis ability	1

Information on culture and growth conditions Culture and growth conditions

[Ref.: #979]

Culture medium

FASTIDIOUS ANAEROBE BROTH (DSMZ Medium 1203a)

[Ref.: #979]

Culture medium growth

[Ref.: #979]

Culture medium link

Medium recipe at MediaDive

[Ref.: #979]

Culture medium composition

expand / minimize

[Ref.: #979]

Culture medium

COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)

[Ref.: #979]

Culture medium growth

[Ref.: #979]

Culture medium link

Medium recipe at MediaDive

[Ref.: #979]

Culture medium composition

expand / minimize

[Ref.: #979]

Culture medium

CHOPPED MEAT MEDIUM (DSMZ Medium 78)

[Ref.: #979]

Culture medium growth

[Ref.: #979]

Culture medium link

Medium recipe at MediaDive

[Ref.: #979]

Culture medium composition

expand / minimize

[Ref.: #41787]

Culture medium

MEDIUM 20 - for Anaerobic bacteria

[Ref.: #41787]

Culture medium growth

[Ref.: #41787]

Culture medium composition

expand / minimize

[Ref.: #119445]

Culture medium

CIP Medium 20

[Ref.: #119445]

Culture medium growth

[Ref.: #119445]

Culture medium link

Medium recipe provided by DSMZ

		Temperature
[Ref.: #979]	growth	37 °C
[Ref.: #41787]	growth	37 °C
[Ref.: #44796]	growth	37 °C
[Ref.: #67770]	growth	37 °C

[Ref.: #979]	Temperature range	mesophilic
[Ref.: #41787]	Temperature range	mesophilic
[Ref.: #44796]	Temperature range	mesophilic
[Ref.: #67770]	Temperature range	mesophilic

Information on physiology and metabolism Physiology and metabolism

[Ref.: #979]	Oxygen tolerance	anaerobe
[Ref.: #44796]	Oxygen tolerance	anaerobe
[Ref.: #119445]	Oxygen tolerance	anaerobe
[Ref.: #69480]	Oxygen tolerance	anaerobe Confidence in %98.65

[Ref.: #69481]	Ability of spore formation	no Confidence in %100
[Ref.: #69480]	Ability of spore formation	no Confidence in %99.954

	Metabolite	Utilization activity	Kind of utilization tested
[Ref.: #68380]	arginine ChEBI	-	hydrolysis	* from API rID32A
[Ref.: #68367]	D-glucose ChEBI	+	builds acid from	* from API 20A
[Ref.: #68367]	D-mannitol ChEBI	-	builds acid from	* from API 20A
[Ref.: #68367]	D-mannose ChEBI	+	builds acid from	* from API 20A
[Ref.: #68380]	D-mannose ChEBI	+	fermentation	* from API rID32A
[Ref.: #68367]	D-xylose ChEBI	+	builds acid from	* from API 20A
[Ref.: #119445]	esculin ChEBI	+	hydrolysis
[Ref.: #68367]	esculin ChEBI	+	hydrolysis	* from API 20A
[Ref.: #68367]	gelatin ChEBI	-	hydrolysis	* from API 20A
[Ref.: #68367]	glycerol ChEBI	-	builds acid from	* from API 20A
[Ref.: #119445]	hippurate ChEBI	-	hydrolysis
[Ref.: #68367]	L-arabinose ChEBI	-	builds acid from	* from API 20A
[Ref.: #68380]	L-glutamate ChEBI	+	degradation	* from API rID32A
[Ref.: #68367]	L-rhamnose ChEBI	-	builds acid from	* from API 20A
[Ref.: #68367]	lactose ChEBI	+	builds acid from	* from API 20A
[Ref.: #68367]	maltose ChEBI	+	builds acid from	* from API 20A
[Ref.: #68367]	melezitose ChEBI	-	builds acid from	* from API 20A
[Ref.: #119445]	nitrate ChEBI	-	reduction
[Ref.: #119445]	nitrate ChEBI	+	respiration
[Ref.: #68380]	nitrate ChEBI	-	reduction	* from API rID32A
[Ref.: #119445]	nitrite ChEBI	-	reduction
[Ref.: #68367]	raffinose ChEBI	+	builds acid from	* from API 20A
[Ref.: #68380]	raffinose ChEBI	+	fermentation	* from API rID32A
[Ref.: #68367]	salicin ChEBI	-	builds acid from	* from API 20A
[Ref.: #68367]	sorbitol ChEBI	-	builds acid from	* from API 20A
[Ref.: #68367]	sucrose ChEBI	+	builds acid from	* from API 20A
[Ref.: #68367]	trehalose ChEBI	-	builds acid from	* from API 20A
[Ref.: #68367]	tryptophan ChEBI	-	energy source	* from API 20A, API rID32A
[Ref.: #68367]	urea ChEBI	-	hydrolysis	* from API 20A, API rID32A
	Only first 10 entries are displayed. Click here to see all.

	Metabolite production	Metabolite	Production
[Ref.: #119445]		indole ChEBI	no
[Ref.: #68367]		indole ChEBI	no	* from API 20A, API rID32A

	Physiological tests	Metabolite	Indole test
[Ref.: #68380]		indole ChEBI	-	* from API rID32A, API 20A

	Enzyme	Enzyme activity	EC number
[Ref.: #68382]	acid phosphatase	+	3.1.3.2	* from API zym
[Ref.: #68380]	alanine arylamidase	+	3.4.11.2	* from API rID32A
[Ref.: #119445]	alcohol dehydrogenase	-	1.1.1.1
[Ref.: #68382]	alkaline phosphatase	+	3.1.3.1	* from API zym, API rID32A
[Ref.: #68380]	alpha-arabinosidase	-	3.2.1.55	* from API rID32A
[Ref.: #68382]	alpha-chymotrypsin	-	3.4.21.1	* from API zym
[Ref.: #68382]	alpha-fucosidase	+	3.2.1.51	* from API zym, API rID32A
[Ref.: #68382]	alpha-galactosidase	+	3.2.1.22	* from API zym, API rID32A
[Ref.: #68382]	alpha-glucosidase	+	3.2.1.20	* from API zym, API rID32A
[Ref.: #68382]	alpha-mannosidase	-	3.2.1.24	* from API zym
[Ref.: #119445]	amylase	-
[Ref.: #68380]	arginine dihydrolase	-	3.5.3.6	* from API rID32A
[Ref.: #119445]	beta-galactosidase	+	3.2.1.23
[Ref.: #68382]	beta-galactosidase	+	3.2.1.23	* from API zym, API rID32A
[Ref.: #68380]	beta-Galactosidase 6-phosphate	-		* from API rID32A
[Ref.: #68380]	beta-glucosidase	+	3.2.1.21	* from API rID32A, API 20A
[Ref.: #68382]	beta-glucosidase	-	3.2.1.21	* from API zym
[Ref.: #68382]	beta-glucuronidase	+	3.2.1.31	* from API zym
[Ref.: #119445]	caseinase	+	3.4.21.50
[Ref.: #119445]	catalase	-	1.11.1.6
[Ref.: #68367]	catalase	+	1.11.1.6	* from API 20A
[Ref.: #68382]	cystine arylamidase	-	3.4.11.3	* from API zym
[Ref.: #119445]	DNase	-
[Ref.: #68382]	esterase (C 4)	+		* from API zym
[Ref.: #68382]	esterase lipase (C 8)	+		* from API zym
[Ref.: #119445]	gelatinase	+
[Ref.: #68367]	gelatinase	-		* from API 20A
[Ref.: #68380]	glutamate decarboxylase	+	4.1.1.15	* from API rID32A
[Ref.: #68380]	glycin arylamidase	-		* from API rID32A
[Ref.: #119445]	lecithinase	-
[Ref.: #68382]	leucine arylamidase	+	3.4.11.1	* from API zym
[Ref.: #68380]	leucyl glycin arylamidase	+	3.4.11.1	* from API rID32A
[Ref.: #119445]	lipase	-
[Ref.: #68382]	lipase (C 14)	-		* from API zym
[Ref.: #119445]	lysine decarboxylase	-	4.1.1.18
[Ref.: #68382]	N-acetyl-beta-glucosaminidase	+	3.2.1.52	* from API zym, API rID32A
[Ref.: #68382]	naphthol-AS-BI-phosphohydrolase	+		* from API zym
[Ref.: #119445]	ornithine decarboxylase	-	4.1.1.17
[Ref.: #119445]	oxidase	-
[Ref.: #68380]	proline-arylamidase	-	3.4.11.5	* from API rID32A
[Ref.: #119445]	protease	-
[Ref.: #68380]	pyrrolidonyl arylamidase	-	3.4.19.3	* from API rID32A
[Ref.: #68380]	serine arylamidase	-		* from API rID32A
[Ref.: #68382]	trypsin	-	3.4.21.4	* from API zym
[Ref.: #68380]	tryptophan deaminase	-	4.1.99.1	* from API rID32A
[Ref.: #119445]	tween esterase	-
[Ref.: #119445]	urease	-	3.5.1.5
[Ref.: #68380]	urease	-	3.5.1.5	* from API rID32A, API 20A
[Ref.: #68382]	valine arylamidase	-		* from API zym
	Only first 10 entries are displayed. Click here to see all.

API® 20A:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Indole productionIND	Urease/urea hydrolysisURE	Acid from D-glucoseGLU	Acid from D-mannitolMAN	Acid from lactoseLAC	Acid from sucroseSAC	Acid from maltoseMAL	Acid from salicinSAL	Acid from D-xyloseXYL	Acid from L-arabinoseARA	Gelatinase/gelatin hydrolysisGEL	Esculin hydrolysis/beta-glucosidaseESC	Acid from glycerolGLY	Acid from cellobioseCEL	Acid from D-mannoseMNE	Acid from melezitoseMLZ	Acid from raffinoseRAF	Acid from sorbitolSOR	Acid from L-rhamnoseRHA	Acid from trehaloseTRE	CatalaseCAT	Spores presentSPOR	GramGRAM	Morphology coccus="+" rod="-"COCC
[Ref.: #979]	2003	-	-	+	-	+	+	+	-	+	-	-	+	-	+/-	+	-	+	-	-	-	not determinedn.d.	not determinedn.d.	not determinedn.d.	not determinedn.d.
[Ref.: #979]	2002	-	-	+	-	+	+	+	-	+	-	-	+	-	+/-	+	-	+	-	-	-	+	not determinedn.d.	not determinedn.d.	not determinedn.d.

API® rID32A:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Urease/urea hydrolysisURE	Arginine dihydrolaseADH (Arg)	alpha-Galactosidasealpha GAL	beta-Galactosidasebeta GAL	beta-Galactosidase 6-phosphatebeta GP	alpha-Glucosidasealpha GLU	beta-Glucosidasebeta GLU	alpha-Arabinosidasealpha ARA	beta-Glucuronidasebeta GUR	beta-N-Acetyl-beta-glucosaminidasebeta NAG	Fermentation of D-mannoseMNE	Fermentation of raffinoseRAF	Glutamate decarboxylaseGDC	alpha-Fucosidasealpha FUC	Reduction of nitrateNIT	Indole productionIND	Alkaline phosphatasePAL	L-arginine arylamidaseArgA	Proline arylamidaseProA	Leucyl glycin arylamidaseLGA	Phenylalanine arylamidasePheA	Leucine arylamidaseLeuA	Pyrrolidonyl arylamidasePyrA	Tyrosine arylamidaseTyrA	Alanine arylamidaseAlaA	Glycin arylamidaseGlyA	Histidine arylamidaseHisA	Glutamyl-glutamate arylamidaseGGA	Serine arylamidaseSerA
[Ref.: #979]	13313	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	+/-	-	+	-	+	-	-	+	-	-	+	-
[Ref.: #979]	12125	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	+	-	+	-	+	-	+	+	-	-	+	-
[Ref.: #979]	12126	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	+	-	+	-	+	-	+	+	-	-	+	-
[Ref.: #979]	12127	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	+/-	-	+	-	+/-	-	-	+	-	-	+/-	-
[Ref.: #979]	12128	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	+	-	+	-	+/-	-	+	+	-	-	+	-
[Ref.: #979]	12129	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	+/-	-	+	-	+	-	-	+	-	-	+/-	-
[Ref.: #979]	12130	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	-	-	+	-	+	-	-	+	-	-	-	-
[Ref.: #979]	12131	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	+/-	-	+	-	+	-	-	+	-	-	+/-	-
[Ref.: #979]	12132	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	+	-	+	-	+	-	+/-	+	-	-	-	-
[Ref.: #979]	12133	-	-	+	+	-	+	+	-	+/-	+	+	+	+	+	-	-	+	+	-	+	-	+	-	-	+	-	-	+	-
[Ref.: #979]	12938	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	+	-	+	-	+	-	+/-	+	-	+/-	+	-
[Ref.: #979]	13037	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	+	-	+	-	+	-	+	+	-	-	+	-
[Ref.: #979]	13168	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	-	-	+	-	+/-	-	-	+	-	-	+/-	-
[Ref.: #979]	13410	-	-	+	+	-	+	+	-	-	+	+	+	+	+	-	-	+	+	-	+	+/-	+	-	+	+	-	+/-	+	-

API® zym:

Note that the displayed test results represent raw data and therefore may deviate!

	API ID	Control	2-naphthyl phosphateAlkaline phosphatase	2-naphthyl butyrateEsterase (C 4)	2-naphtyl caprylateEsterase Lipase (C 8)	2-naphthyl myristateLipase (C 14)	L-leucyl-2-naphthylamideLeucine arylamidase	L-valyl-2-naphthylamideValine arylamidase	L-cystyl-2-naphthylamideCystine arylamidase	N-benzoyl-DL-arginine-2-naphthylamideTrypsin	N-glutaryl-phenylalanine-2-naphthylamidealpha- Chymotrypsin	2-naphthyl phosphateAcid phosphatase	Naphthol-AS-BI-phosphateNaphthol-AS-BI-phosphohydrolase	6-Br-2-naphthyl-alphaD-galactpyranosidealpha- Galactosidase	2-naphthyl-betaD-galactpyranosidebeta- Galactosidase	Naphthol-AS-BI-betaD-glucuronidebeta- Glucuronidase	2-naphthyl-alphaD-glucopyranosidealpha- Glucosidase	6-Br-2-naphthyl-betaD-glucopyranosidebeta- Glucosidase	1-naphthyl-N-acetyl-betaD-glucosaminideN-acetyl-beta- glucosaminidase	6-Br-2-naphthyl-alphaD-mannopyranosidealpha- Mannosidase	2-naphthyl-alphaL-fucopyranosidealpha- Fucosidase
[Ref.: #119445]	13379	-	+	+	+	-	+	-	-	-	-	+	+	+	+	+	+	-	+	-	+

	Pathway	Enzyme coverage	Annotated reactions
	Pathway annotation	Computationally determined by
[Ref.: #66794]	methylglyoxal degradation	100	5 of 5
[Ref.: #66794]	formaldehyde oxidation	100	3 of 3
[Ref.: #66794]	vitamin K metabolism	100	5 of 5
[Ref.: #66794]	glycogen metabolism	100	5 of 5
[Ref.: #66794]	d-mannose degradation	100	9 of 9
[Ref.: #66794]	cis-vaccenate biosynthesis	100	2 of 2
[Ref.: #66794]	CMP-KDO biosynthesis	100	4 of 4
[Ref.: #66794]	L-lactaldehyde degradation	100	3 of 3
[Ref.: #66794]	ethanol fermentation	100	2 of 2
[Ref.: #66794]	biotin biosynthesis	100	4 of 4
[Ref.: #66794]	starch degradation	100	10 of 10
[Ref.: #66794]	lipoate biosynthesis	100	5 of 5
[Ref.: #66794]	palmitate biosynthesis	100	22 of 22
[Ref.: #66794]	acetate fermentation	100	4 of 4
[Ref.: #66794]	ppGpp biosynthesis	100	4 of 4
[Ref.: #66794]	coenzyme A metabolism	100	4 of 4
[Ref.: #66794]	sulfopterin metabolism	100	4 of 4
[Ref.: #66794]	suberin monomers biosynthesis	100	2 of 2
[Ref.: #66794]	anapleurotic synthesis of oxalacetate	100	1 of 1
[Ref.: #66794]	CDP-diacylglycerol biosynthesis	100	2 of 2
[Ref.: #66794]	folate polyglutamylation	100	1 of 1
[Ref.: #66794]	teichoic acid biosynthesis	100	1 of 1
[Ref.: #66794]	gluconeogenesis	100	8 of 8
[Ref.: #66794]	C4 and CAM-carbon fixation	100	8 of 8
[Ref.: #66794]	tetrahydrofolate metabolism	92.86	13 of 14
[Ref.: #66794]	propionate fermentation	90	9 of 10
[Ref.: #66794]	chorismate metabolism	88.89	8 of 9
[Ref.: #66794]	aspartate and asparagine metabolism	88.89	8 of 9
[Ref.: #66794]	valine metabolism	88.89	8 of 9
[Ref.: #66794]	lipid A biosynthesis	88.89	8 of 9
[Ref.: #66794]	isoleucine metabolism	87.5	7 of 8
[Ref.: #66794]	propanol degradation	85.71	6 of 7
[Ref.: #66794]	phenylalanine metabolism	84.62	11 of 13
[Ref.: #66794]	NAD metabolism	83.33	15 of 18
[Ref.: #66794]	vitamin B6 metabolism	81.82	9 of 11
[Ref.: #66794]	pentose phosphate pathway	81.82	9 of 11
[Ref.: #66794]	flavin biosynthesis	80	12 of 15
[Ref.: #66794]	pyrimidine metabolism	80	36 of 45
[Ref.: #66794]	O-antigen biosynthesis	80	4 of 5
[Ref.: #66794]	metabolism of amino sugars and derivatives	80	4 of 5
[Ref.: #66794]	cellulose degradation	80	4 of 5
[Ref.: #66794]	threonine metabolism	80	8 of 10
[Ref.: #66794]	glycine betaine biosynthesis	80	4 of 5
[Ref.: #66794]	peptidoglycan biosynthesis	80	12 of 15
[Ref.: #66794]	alanine metabolism	79.31	23 of 29
[Ref.: #66794]	photosynthesis	78.57	11 of 14
[Ref.: #66794]	serine metabolism	77.78	7 of 9
[Ref.: #66794]	purine metabolism	77.66	73 of 94
[Ref.: #66794]	vitamin B1 metabolism	76.92	10 of 13
[Ref.: #66794]	vitamin B12 metabolism	76.47	26 of 34
[Ref.: #66794]	glycolysis	76.47	13 of 17
[Ref.: #66794]	glycogen biosynthesis	75	3 of 4
[Ref.: #66794]	histidine metabolism	72.41	21 of 29
[Ref.: #66794]	cardiolipin biosynthesis	71.43	5 of 7
[Ref.: #66794]	citric acid cycle	71.43	10 of 14
[Ref.: #66794]	Entner Doudoroff pathway	70	7 of 10
[Ref.: #66794]	glutamate and glutamine metabolism	67.86	19 of 28
[Ref.: #66794]	UDP-GlcNAc biosynthesis	66.67	2 of 3
[Ref.: #66794]	octane oxidation	66.67	2 of 3
[Ref.: #66794]	cyanate degradation	66.67	2 of 3
[Ref.: #66794]	acetoin degradation	66.67	2 of 3
[Ref.: #66794]	non-pathway related	65.79	25 of 38
[Ref.: #66794]	isoprenoid biosynthesis	65.38	17 of 26
[Ref.: #66794]	d-xylose degradation	63.64	7 of 11
[Ref.: #66794]	6-hydroxymethyl-dihydropterin diphosphate biosynthesis	62.5	5 of 8
[Ref.: #66794]	leucine metabolism	61.54	8 of 13
[Ref.: #66794]	degradation of hexoses	61.11	11 of 18
[Ref.: #66794]	hydrogen production	60	3 of 5
[Ref.: #66794]	lysine metabolism	59.52	25 of 42
[Ref.: #66794]	heme metabolism	57.14	8 of 14
[Ref.: #66794]	ubiquinone biosynthesis	57.14	4 of 7
[Ref.: #66794]	degradation of sugar alcohols	56.25	9 of 16
[Ref.: #66794]	CO2 fixation in Crenarchaeota	55.56	5 of 9
[Ref.: #66794]	proline metabolism	54.55	6 of 11
[Ref.: #66794]	methionine metabolism	53.85	14 of 26
[Ref.: #66794]	degradation of pentoses	53.57	15 of 28
[Ref.: #66794]	butanoate fermentation	50	2 of 4
[Ref.: #66794]	dTDPLrhamnose biosynthesis	50	4 of 8
[Ref.: #66794]	ketogluconate metabolism	50	4 of 8
[Ref.: #66794]	adipate degradation	50	1 of 2
[Ref.: #66794]	aminopropanol phosphate biosynthesis	50	1 of 2
[Ref.: #66794]	pantothenate biosynthesis	50	3 of 6
[Ref.: #66794]	coenzyme M biosynthesis	50	5 of 10
[Ref.: #66794]	tryptophan metabolism	50	19 of 38
[Ref.: #66794]	phenylmercury acetate degradation	50	1 of 2
[Ref.: #66794]	selenocysteine biosynthesis	50	3 of 6
[Ref.: #66794]	toluene degradation	50	2 of 4
[Ref.: #66794]	arginine metabolism	45.83	11 of 24
[Ref.: #66794]	lipid metabolism	45.16	14 of 31
[Ref.: #66794]	cysteine metabolism	44.44	8 of 18
[Ref.: #66794]	polyamine pathway	43.48	10 of 23
[Ref.: #66794]	oxidative phosphorylation	42.86	39 of 91
[Ref.: #66794]	reductive acetyl coenzyme A pathway	42.86	3 of 7
[Ref.: #66794]	tyrosine metabolism	42.86	6 of 14
[Ref.: #66794]	degradation of aromatic, nitrogen containing compounds	41.67	5 of 12
[Ref.: #66794]	arachidonate biosynthesis	40	2 of 5
[Ref.: #66794]	factor 420 biosynthesis	40	2 of 5
[Ref.: #66794]	glycine metabolism	40	4 of 10
[Ref.: #66794]	myo-inositol biosynthesis	40	4 of 10
[Ref.: #66794]	urea cycle	38.46	5 of 13
[Ref.: #66794]	phenylpropanoid biosynthesis	38.46	5 of 13
[Ref.: #66794]	sulfate reduction	38.46	5 of 13
[Ref.: #66794]	androgen and estrogen metabolism	37.5	6 of 16
[Ref.: #66794]	ascorbate metabolism	36.36	8 of 22
[Ref.: #66794]	metabolism of disaccharids	36.36	4 of 11
[Ref.: #66794]	degradation of sugar acids	36	9 of 25
[Ref.: #66794]	glutathione metabolism	35.71	5 of 14
[Ref.: #66794]	molybdenum cofactor biosynthesis	33.33	3 of 9
[Ref.: #66794]	enterobactin biosynthesis	33.33	1 of 3
[Ref.: #66794]	glycolate and glyoxylate degradation	33.33	2 of 6
[Ref.: #66794]	IAA biosynthesis	33.33	1 of 3
[Ref.: #66794]	nitrate assimilation	33.33	3 of 9
[Ref.: #66794]	acetyl CoA biosynthesis	33.33	1 of 3
[Ref.: #66794]	arachidonic acid metabolism	27.78	5 of 18
[Ref.: #66794]	cyclohexanol degradation	25	1 of 4
[Ref.: #66794]	lactate fermentation	25	1 of 4
[Ref.: #66794]	catecholamine biosynthesis	25	1 of 4
[Ref.: #66794]	phosphatidylethanolamine bioynthesis	23.08	3 of 13
		Only first 10 entries are displayed. Click here to see all.

Information on isolation source, the sampling and environmental conditions Isolation, sampling and environmental information

[Ref.: #979]	Sample type/isolated from	appendix abscess
[Ref.: #979]	Country	United Kingdom
[Ref.: #979]	Country ISO 3 Code	GBR
[Ref.: #979]	Continent	Europe

[Ref.: #44796]	Sample type/isolated from	Appendix abscess

[Ref.: #67770]	Sample type/isolated from	Appendix abscess

[Ref.: #119445]	Sample type/isolated from	Human, Appendix
[Ref.: #119445]	Country	United Kingdom
[Ref.: #119445]	Country ISO 3 Code	GBR
[Ref.: #119445]	Continent	Europe
* marker position based on {}

Isolation sources categories

#Host Body-Site	#Gastrointestinal tract	#Large intestine
#Host Body-Site	#Other	#Abscess

What are isolation sources categories?

[Ref.: #69479]

Global distribution of 16S sequence X83935 (>99% sequence identity) for Bacteroides fragilis subclade from Microbeatlas

Aquatic Samples	7159
Soil Samples	2825
Animal Samples	211201
Plant Samples	810
Total Samples	221995

Information on possible application of the strain and its possible interaction with e.g. potential hosts Safety information

[Ref.: #979]	Pathogenicity (human)	yes
[Ref.: #979]	Pathogenicity (animal)	yes
[Ref.: #979]	Biosafety level	2	Risk group (German classification) According to TRBA 466
[Ref.: #119445]	Biosafety level	2	Risk group (French classification)

Information on genomic background e.g. entries in nucleic sequence databass Sequence information

16S Sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Sequence length (bp)	Sequence database	Associated NCBI tax ID
[Ref.: #67770]	Bacteroides fragilis gene for 16S ribosomal RNA, partial sequence, strain: JCM 11019	AB510701	1490	ENA	817 tax ID
[Ref.: #20218]	B.fragilis 16S rRNA (ATCC 25285T)	X83935	1436	ENA	817 tax ID	*
[Ref.: #20218]	Bacteroides fragilis strain DSM 2151 16S ribosomal RNA gene, partial sequence	HQ012027	933	ENA	817 tax ID	*
[Ref.: #20218]	Bacteroides fragilis 16S-23S ribosomal RNA intergenic spacer region, partial sequence	AF172709	481	ENA	817 tax ID	*
[Ref.: #20218]	Bacteroides fragilis strain ATCC 25285 16S ribosomal RNA gene, partial sequence	HM353002	383	ENA	817 tax ID	*
[Ref.: #20218]	Bacteroides fragilis ATCC:25285 16S ribosomal RNA gene, partial sequence; 16S-23S ribosomal intergenic spacer, complete sequence; and 23S ribosomal RNA gene, partial sequence	FJ410381	3379	ENA	817 tax ID	*
[Ref.: #20218]	Bacteroides fragilis partial 16S rRNA gene, strain ATCC 25285	FM207089	382	ENA	817 tax ID	*
[Ref.: #20218]	Bacteroides fragilis gene for 16S rRNA, partial sequence	AB050106	1404	ENA	817 tax ID	*

Genome sequence information:

Only first 5 entries are displayed. Click here to see all.

	Sequence accession description	Seq. accession number	Assembly level	Sequence database	Associated NCBI tax ID
[Ref.: #67770]	Bacteroides fragilis CCUG4856T	GCA_005706655	complete	GenBank	817 tax ID
[Ref.: #66792]	Bacteroides fragilis ATCC 25285	GCA_001997325	scaffold	GenBank	817 tax ID	*
[Ref.: #66792]	Bacteroides fragilis NCTC 9343	272559.47	wgs	PATRIC	272559 tax ID	*
[Ref.: #66792]	Bacteroides fragilis NCTC 9343 strain ATCC 25285	272559.41	plasmid	PATRIC	272559 tax ID	*
[Ref.: #66792]	Bacteroides fragilis NCTC 9343 strain ATCC 25285	272559.17	complete	PATRIC	272559 tax ID	*
[Ref.: #66792]	Bacteroides fragilis strain ATCC 25285	817.168	wgs	PATRIC	817 tax ID	*

[Ref.: #979]	GC-content	42.0 mol%
[Ref.: #979]	GC-content	43.1 mol%	sequence analysis
[Ref.: #67770]	GC-content	42 mol%	thermal denaturation, midpoint method (Tm)

Data predicted using genome information as a basis Genome-based predictions

	Trait	Prediction	Confidence in %	In training data
	Predictions from GenomeNet Sporulation v. 1 based on: Bacteroides fragilis NCTC 9343 NCTC 9343 NCBI: GCA_000025985.1
[Ref.: #69481]	spore-forming	no	100	no

	Trait	Prediction	Confidence in %	In training data
	Predictions from Diaspora project based on: Bacteroides fragilis NCTC 9343 NCTC 9343 NCBI: GCA_000025985.1
[Ref.: #69480]	motile	no	92.042	no
[Ref.: #69480]	flagellated	no	97.421	no
[Ref.: #69480]	gram-positive	no	95.874	no
[Ref.: #69480]	anaerobic	yes	95.832	yes
[Ref.: #69480]	aerobic	no	95.647	no
[Ref.: #69480]	halophile	no	90.896	no
[Ref.: #69480]	spore-forming	no	92.521	no
[Ref.: #69480]	thermophile	no	99.637	yes
[Ref.: #69480]	glucose-util	yes	87.195	no
[Ref.: #69480]	glucose-ferment	yes	66.155	no

Availability in culture collections External links

[Ref.: #979]

Culture collection no.

DSM 2151, ATCC 25285, JCM 11019, NCTC 9343, CCUG 4856, CCM 4712, VPI 2553, CIP 77.16, KCTC 3688, KCTC 5013, LMG 10263, LMG 11261, NCDO 2217

[Ref.: #71230]

SI-ID 389404

Literature:

Only first 10 entries are displayed. Click here to see all.

Topic	Title	Authors	Journal	DOI	Year
Metabolism	Identification of a protective Bacteroides strain of alcoholic liver disease and its synergistic effect with pectin.	Wang Q, Li Y, Lv L, Jiang H, Yan R, Wang S, Lu Y, Wu Z, Shen J, Jiang S, Lv J, Li S, Zhuge A, Li L	Appl Microbiol Biotechnol	10.1007/s00253-022-11946-7	2022	*
Phylogeny	Paraphocaeicola brunensis gen. nov., sp. nov., Carrying Two Variants of nimB Resistance Gene from Bacteroides fragilis, and Caecibacteroides pullorum gen. nov., sp. nov., Two Novel Genera Isolated from Chicken Caeca.	Kralova S, Davidova-Gerzova L, Valcek A, Bezdicek M, Rychlik I, Rezacova V, Cizek A	Microbiol Spectr	10.1128/spectrum.01954-21	2022	*
Phylogeny	Genomic Background and Phylogeny of cfiA-Positive Bacteroides fragilis Strains Resistant to Meropenem-EDTA.	Valdezate S, Cobo F, Monzon S, Medina-Pascual MJ, Zaballos A, Cuesta I, Pino-Rosa S, Villalon P	Antibiotics (Basel)	10.3390/antibiotics10030304	2021	*
Pathogenicity	In-laboratory quality control of nutrients for automatic bacteriology analyzer YUNON(R)Labstar 50.	Boronina LG, Samatova EV, Kukushkina MP, Panova SA, Ustyugova SS	Klin Lab Diagn	10.51620/0869-2084-2021-66-2-110-114	2021	*
Metabolism	Bacteroides fragilis alleviates the symptoms of lupus nephritis via regulating CD1d and CD86 expressions in B cells.	Li D, Pan Y, Xia X, Liang J, Liu F, Dou H, Hou Y	Eur J Pharmacol	10.1016/j.ejphar.2020.173421	2020	*
Metabolism	Screening and characterization of an alpha-L-fucosidase from Bacteroides fragilis NCTC9343 for synthesis of fucosyl-N-acetylglucosamine disaccharides.	Liu P, Zhang H, Wang Y, Chen X, Jin L, Xu L, Xiao M	Appl Microbiol Biotechnol	10.1007/s00253-020-10759-w	2020	*
Genetics	Complete hybrid genome assembly of clinical multidrug-resistant Bacteroides fragilis isolates enables comprehensive identification of antimicrobial-resistance genes and plasmids.	Sydenham TV, Overballe-Petersen S, Hasman H, Wexler H, Kemp M, Justesen US	Microb Genom	10.1099/mgen.0.000312	2019	*
Pathogenicity	Binary interactions between the yeast Candida albicans and two gut-associated Bacteroides species.	Valentine M, Benade E, Mouton M, Khan W, Botha A	Microb Pathog	10.1016/j.micpath.2019.103619	2019	*
Pathogenicity	Non-toxigenic Bacteroides fragilis (NTBF) administration reduces bacteria-driven chronic colitis and tumor development independent of polysaccharide A.	Chan JL, Wu S, Geis AL, Chan GV, Gomes TAM, Beck SE, Wu X, Fan H, Tam AJ, Chung L, Ding H, Wang H, Pardoll DM, Housseau F, Sears CL	Mucosal Immunol	10.1038/s41385-018-0085-5	2018	*
Enzymology	Enzymatic Synthesis of 6'-Sialyllactose, a Dominant Sialylated Human Milk Oligosaccharide, by a Novel exo-alpha-Sialidase from Bacteroides fragilis NCTC9343.	Guo L, Chen X, Xu L, Xiao M, Lu L	Appl Environ Microbiol	10.1128/AEM.00071-18	2018	*
Pathogenicity	Antimicrobial susceptibility testing of Bacteroides fragilis using the MALDI Biotyper antibiotic susceptibility test rapid assay (MBT-ASTRA).	Justesen US, Acar Z, Sydenham TV, Johansson A	Anaerobe	10.1016/j.anaerobe.2018.02.007	2018	*
Pathogenicity	Orthopedic infections caused by obligatory anaerobic Gram-negative rods: report of two cases.	Kierzkowska M, Pedzisz P, Babiak I, Janowicz J, Kulig M, Majewska A, Sawicka-Grzelak A, Mlynarczyk G	Med Microbiol Immunol	10.1007/s00430-017-0513-2	2017	*
Pathogenicity	Implementation of the new VIRTUO blood culture system: evaluation and comparison to the 3D system using simulated blood cultures.	Miller N, Brassinne L, Allemeersch D	Acta Clin Belg	10.1080/17843286.2017.1331618	2017	*
Metabolism	[Design of artificial foetor flatus based on bacterial volatile compounds].	Justesen US	Ugeskr Laeger	V68707	2016	*
Enzymology	Efficient and Regioselective Synthesis of beta-GalNAc/GlcNAc-Lactose by a Bifunctional Transglycosylating beta-N-Acetylhexosaminidase from Bifidobacterium bifidum.	Chen X, Xu L, Jin L, Sun B, Gu G, Lu L, Xiao M	Appl Environ Microbiol	10.1128/AEM.01325-16	2016	*
Phylogeny	Genomic Diversity of Enterotoxigenic Strains of Bacteroides fragilis.	Pierce JV, Bernstein HD	PLoS One	10.1371/journal.pone.0158171	2016	*
Metabolism	Efficient and regioselective synthesis of globotriose by a novel alpha-galactosidase from Bacteroides fragilis.	Gong W, Xu L, Gu G, Lu L, Xiao M	Appl Microbiol Biotechnol	10.1007/s00253-016-7464-1	2016	*
Pathogenicity	Immunological evaluation of the entirely carbohydrate-based Thomsen-Friedenreich - PS B conjugate.	Trabbic KR, Bourgault JP, Shi M, Clark M, Andreana PR	Org Biomol Chem	10.1039/c6ob00176a	2016	*
Metabolism	DNA Inversion Regulates Outer Membrane Vesicle Production in Bacteroides fragilis.	Nakayama-Imaohji H, Hirota K, Yamasaki H, Yoneda S, Nariya H, Suzuki M, Secher T, Miyake Y, Oswald E, Hayashi T, Kuwahara T	PLoS One	10.1371/journal.pone.0148887	2016	*
Metabolism	Structures of Bacteroides fragilis uridine 5'-diphosphate-N-acetylglucosamine (UDP-GlcNAc) acyltransferase (BfLpxA).	Ngo A, Fong KT, Cox DL, Chen X, Fisher AJ	Acta Crystallogr D Biol Crystallogr	10.1107/S1399004715003326	2015	*
Proteome	Analysis of the outer membrane proteome and secretome of Bacteroides fragilis reveals a multiplicity of secretion mechanisms.	Wilson MM, Anderson DE, Bernstein HD	PLoS One	10.1371/journal.pone.0117732	2015	*
Phylogeny	[Isolation and identification of a non-enterotoxigenic strain of Bacteroides fragilis from a healthy term infant].	Liu Y, Zhang W, Bai Y, Zhi F	Zhonghua Yi Xue Za Zhi		2014	*
Pathogenicity	Essential oils and isolated compounds from Lippia alba leaves and flowers: antimicrobial activity and osteoclast apoptosis.	Juiz PJ, Lucchese AM, Gambari R, Piva R, Penolazzi L, Di Ciano M, Uetanabaro AP, Silva F, Avila-Campos MJ	Int J Mol Med	10.3892/ijmm.2014.1995	2014	*
Metabolism	Identification of a collagen type I adhesin of Bacteroides fragilis.	Galvao BP, Weber BW, Rafudeen MS, Ferreira EO, Patrick S, Abratt VR	PLoS One	10.1371/journal.pone.0091141	2014	*
Metabolism	ArdA proteins from different mobile genetic elements can bind to the EcoKI Type I DNA methyltransferase of E. coli K12.	Chen K, Reuter M, Sanghvi B, Roberts GA, Cooper LP, Tilling M, Blakely GW, Dryden DT	Biochim Biophys Acta	10.1016/j.bbapap.2013.12.008	2013	*
Enzymology	The mannobiose-forming exo-mannanase involved in a new mannan catabolic pathway in Bacteroides fragilis.	Kawaguchi K, Senoura T, Ito S, Taira T, Ito H, Wasaki J, Ito S	Arch Microbiol	10.1007/s00203-013-0938-y	2013	*
Pathogenicity	Growth-Inhibiting and morphostructural effects of constituents identified in Asarum heterotropoides root on human intestinal bacteria.	Perumalsamy H, Jung MY, Hong SM, Ahn YJ	BMC Complement Altern Med	10.1186/1472-6882-13-245	2013	*
Phylogeny	Use of a genetically-engineered Escherichia coli strain as a sample process control for quantification of the host-specific bacterial genetic markers.	Kobayashi A, Sano D, Taniuchi A, Ishii S, Okabe S	Appl Microbiol Biotechnol	10.1007/s00253-013-5188-z	2013	*
Metabolism	Production of alpha-galactosylceramide by a prominent member of the human gut microbiota.	Wieland Brown LC, Penaranda C, Kashyap PC, Williams BB, Clardy J, Kronenberg M, Sonnenburg JL, Comstock LE, Bluestone JA, Fischbach MA	PLoS Biol	10.1371/journal.pbio.1001610	2013	*
Pathogenicity	Determination of disk diffusion and MIC quality control guidelines for GSK2251052: a novel boron-containing antibacterial.	Ross JE, Scangarella-Oman N, Jones RN	Diagn Microbiol Infect Dis	10.1016/j.diagmicrobio.2013.01.007	2013	*
Pathogenicity	Anti-anaerobic potential of ranbezolid: insight into its mechanism of action against Bacteroides fragilis.	Mathur T, Kalia V, Barman TK, Singhal S, Khan S, Upadhyay DJ, Rattan A, Raj VS	Int J Antimicrob Agents	10.1016/j.ijantimicag.2012.09.013	2012	*
Enzymology	Identification of a TLR2-stimulating lipoprotein in Bacteroides fragilis JCM 11019 (NCTC 9343).	Hashimoto M, Eguchi H, Tawaratsumida K, Kirikae T, Suda Y	Innate Immun	10.1177/1753425912454179	2012	*
Cultivation	Contribution of hly homologs to the hemolytic activity of Prevotella intermedia.	Suzuki N, Fukamachi H, Arimoto T, Yamamoto M, Igarashi T	Anaerobe	10.1016/j.anaerobe.2012.04.005	2012	*
Pathogenicity	The entirely carbohydrate immunogen Tn-PS A1 induces a cancer cell selective immune response and cytokine IL-17.	De Silva RA, Appulage DK, Pietraszkiewicz H, Bobbitt KR, Media J, Shaw J, Valeriote FA, Andreana PR	Cancer Immunol Immunother	10.1007/s00262-012-1205-9	2012	*
Metabolism	A unique homologue of the eukaryotic protein-modifier ubiquitin present in the bacterium Bacteroides fragilis, a predominant resident of the human gastrointestinal tract.	Patrick S, Jobling KL, O'Connor D, Thacker Z, Dryden DTF, Blakely GW	Microbiology (Reading)	10.1099/mic.0.049940-0	2011	*
Metabolism	UDP-glucuronic acid decarboxylases of Bacteroides fragilis and their prevalence in bacteria.	Coyne MJ, Fletcher CM, Reinap B, Comstock LE	J Bacteriol	10.1128/JB.05337-11	2011	*
Enzymology	Differentiation of division I (cfiA-negative) and division II (cfiA-positive) Bacteroides fragilis strains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.	Nagy E, Becker S, Soki J, Urban E, Kostrzewa M	J Med Microbiol	10.1099/jmm.0.031336-0	2011	*
Enzymology	The catalytic promiscuity of a microbial 7alpha-hydroxysteroid dehydrogenase. Reduction of non-steroidal carbonyl compounds.	Liu Y, Lv T, Ren J, Wang M, Wu Q, Zhu D	Steroids	10.1016/j.steroids.2011.05.001	2011	*
Metabolism	New microbial mannan catabolic pathway that involves a novel mannosylglucose phosphorylase.	Senoura T, Ito S, Taguchi H, Higa M, Hamada S, Matsui H, Ozawa T, Jin S, Watanabe J, Wasaki J, Ito S	Biochem Biophys Res Commun	10.1016/j.bbrc.2011.04.095	2011	*
Genetics	Twenty-eight divergent polysaccharide loci specifying within- and amongst-strain capsule diversity in three strains of Bacteroides fragilis.	Patrick S, Blakely GW, Houston S, Moore J, Abratt VR, Bertalan M, Cerdeno-Tarraga AM, Quail MA, Corton N, Corton C, Bignell A, Barron A, Clark L, Bentley SD, Parkhill J	Microbiology (Reading)	10.1099/mic.0.042978-0	2010	*
Pathogenicity	In vitro selection of ertapenem and piperacillin/tazobactam-resistant strains of Bacteroides fragilis and analysis of their virulence in gnotobiotic mice.	Valeria Dos Santos K, Roque DE Carvalho MA, Amancio Martins W, Coutinho SC, Bahia JL, Lopes DE Andrade JP, Morais Apolonio AC, Cara DC, Galuppo Diniz C, Nicoli JR, DE Macedo Farias L	J Chemother	10.1179/joc.2010.22.4.259	2010	*
Metabolism	Binding and degradation of fibrinogen by Bacteroides fragilis and characterization of a 54 kDa fibrinogen-binding protein.	Houston S, Blakely GW, McDowell A, Martin L, Patrick S	Microbiology (Reading)	10.1099/mic.0.038588-0	2010	*
Metabolism	Mutational analysis of genes implicated in LPS and capsular polysaccharide biosynthesis in the opportunistic pathogen Bacteroides fragilis.	Patrick S, Houston S, Thacker Z, Blakely GW	Microbiology (Reading)	10.1099/mic.0.025361-0	2009	*
Metabolism	Conversion of cholic acid and chenodeoxycholic acid into their 7-oxo derivatives by Bacteroides intestinalis AM-1 isolated from human feces.	Fukiya S, Arata M, Kawashima H, Yoshida D, Kaneko M, Minamida K, Watanabe J, Ogura Y, Uchida K, Itoh K, Wada M, Ito S, Yokota A	FEMS Microbiol Lett	10.1111/j.1574-6968.2009.01531.x	2009	*
Enzymology	Identification of the cellobiose 2-epimerase gene in the genome of Bacteroides fragilis NCTC 9343.	Senoura T, Taguchi H, Ito S, Hamada S, Matsui H, Fukiya S, Yokota A, Watanabe J, Wasaki J, Ito S	Biosci Biotechnol Biochem	10.1271/bbb.80691	2009	*
Pathogenicity	Presence of quorum-sensing systems associated with multidrug resistance and biofilm formation in Bacteroides fragilis.	Pumbwe L, Skilbeck CA, Wexler HM	Microb Ecol	10.1007/s00248-007-9358-3	2008	*
Pathogenicity	Induction of multiple antibiotic resistance in Bacteroides fragilis by benzene and benzene-derived active compounds of commonly used analgesics, antiseptics and cleaning agents.	Pumbwe L, Skilbeck CA, Wexler HM	J Antimicrob Chemother	10.1093/jac/dkm363	2007	*
Pathogenicity	Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis.	Pumbwe L, Skilbeck CA, Nakano V, Avila-Campos MJ, Piazza RM, Wexler HM	Microb Pathog	10.1016/j.micpath.2007.04.002	2007	*
Pathogenicity	Genetic analysis of mechanisms of multidrug resistance in a clinical isolate of Bacteroides fragilis.	Pumbwe L, Wareham DW, Aduse-Opoku J, Brazier JS, Wexler HM	Clin Microbiol Infect	10.1111/j.1469-0691.2006.01620.x	2007	*
Pathogenicity	Identification and characterization of conjugative transposons CTn86 and CTn9343 in Bacteroides fragilis strains.	Buckwold SL, Shoemaker NB, Sears CL, Franco AA	Appl Environ Microbiol	10.1128/AEM.01669-06	2006	*
Metabolism	Characterization of Bacteroides fragilis hemolysins and regulation and synergistic interactions of HlyA and HlyB.	Robertson KP, Smith CJ, Gough AM, Rocha ER	Infect Immun	10.1128/IAI.74.4.2304-2316.2006	2006	*
Metabolism	In vitro kinetic analysis of oligofructose consumption by Bacteroides and Bifidobacterium spp. indicates different degradation mechanisms.	Van der Meulen R, Makras L, Verbrugghe K, Adriany T, De Vuyst L	Appl Environ Microbiol	10.1128/AEM.72.2.1006-1012.2006	2006	*
Pathogenicity	Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.	Schaumann R, Petzold S, Fille M, Rodloff AC	Infection	10.1007/s15010-005-5061-9	2005	*
Genetics	Genetic and structural analysis of the Bacteroides conjugative transposon CTn341.	Bacic M, Parker AC, Stagg J, Whitley HP, Wells WG, Jacob LA, Smith CJ	J Bacteriol	10.1128/JB.187.8.2858-2869.2005	2005	*
Pathogenicity	The Bacteroides fragilis pathogenicity island is contained in a putative novel conjugative transposon.	Franco AA	J Bacteriol	10.1128/JB.186.18.6077-6092.2004	2004	*
Enzymology	Differential gene expression in a Bacteroides fragilis metronidazole-resistant mutant.	Diniz CG, Farias LM, Carvalho MA, Rocha ER, Smith CJ	J Antimicrob Chemother	10.1093/jac/dkh256	2004	*
Enzymology	Cloning and characterization of the NAD-dependent 7alpha-Hydroxysteroid dehydrogenase from Bacteroides fragilis.	Bennett MJ, McKnight SL, Coleman JP	Curr Microbiol	10.1007/s00284-003-4079-4	2003	*
Pathogenicity	Bacterial reduction by cell salvage washing and leukocyte depletion filtration.	Waters JH, Tuohy MJ, Hobson DF, Procop G	Anesthesiology	10.1097/00000542-200309000-00021	2003	*
Metabolism	Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones.	Ricci V, Piddock L	J Antimicrob Chemother	10.1093/jac/dkg418	2003	*
Metabolism	[The influence of the LPS from Bacteroides fragilis on the secretion of IL-2 and IL-4 from the peripheral blood mononuclear cells of normal volunteers].	Zhou J, Huang XY, Ren LC, Tang Y	Zhonghua Shao Shang Za Zhi		2003	*
Metabolism	Multiple inverted DNA repeats of Bacteroides fragilis that control polysaccharide antigenic variation are similar to the hin region inverted repeats of Salmonella typhimurium.	Patrick S, Parkhill J, McCoy LJ, Lennard N, Larkin MJ, Collins M, Sczaniecka M, Blakely G	Microbiology (Reading)	10.1099/mic.0.26166-0	2003	*
Transcriptome	Characterization of omp200, a porin gene complex from Bacteroides fragilis: omp121 and omp71, gene sequence, deduced amino acid sequences and predictions of porin structure.	Wexler HM, Read EK, Tomzynski TJ	Gene	10.1016/s0378-1119(01)00835-6	2002	*
Pathogenicity	Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis.	White RL, Friedrich LV, Manduru M, Mihm LB, Bosso JA	Diagn Microbiol Infect Dis	10.1016/s0732-8893(00)00219-4	2001	*
Enzymology	Bacteroides fragilis NCTC9343 produces at least three distinct capsular polysaccharides: cloning, characterization, and reassignment of polysaccharide B and C biosynthesis loci.	Coyne MJ, Kalka-Moll W, Tzianabos AO, Kasper DL, Comstock LE	Infect Immun	10.1128/IAI.68.11.6176-6181.2000	2000	*
Metabolism	Accumulation of norfloxacin by Bacteroides fragilis.	Ricci V, Piddock LJ	Antimicrob Agents Chemother	10.1128/AAC.44.9.2361-2366.2000	2000	*
Pathogenicity	Roles of gyrA mutations in resistance of clinical isolates and in vitro mutants of Bacteroides fragilis to the new fluoroquinolone trovafloxacin.	Bachoual R, Dubreuil L, Soussy CJ, Tankovic J	Antimicrob Agents Chemother	10.1128/AAC.44.7.1842-1845.2000	2000	*
Pathogenicity	Effect of molecular size on the ability of zwitterionic polysaccharides to stimulate cellular immunity.	Kalka-Moll WM, Tzianabos AO, Wang Y, Carey VJ, Finberg RW, Onderdonk AB, Kasper DL	J Immunol	10.4049/jimmunol.164.2.719	2000	*
Enzymology	Interstrain variation of the polysaccharide B biosynthesis locus of Bacteroides fragilis: characterization of the region from strain 638R.	Comstock LE, Coyne MJ, Tzianabos AO, Kasper DL	J Bacteriol	10.1128/JB.181.19.6192-6196.1999	1999	*
Enzymology	Activities of the Porphyromonas gingivalis PrtP proteinase determined by construction of prtP-deficient mutants and expression of the gene in Bacteroides species.	Barkocy-Gallagher GA, Foley JW, Lantz MS	J Bacteriol	10.1128/JB.181.1.246-255.1999	1999	*
Metabolism	Mechanism of inhibition of tannic acid and related compounds on the growth of intestinal bacteria.	Chung KT, Lu Z, Chou MW	Food Chem Toxicol	10.1016/s0278-6915(98)00086-6	1998	*
Enzymology	Isolation and characterization of a porin-like protein of 45 kilodaltons from Bacteroides fragilis.	Odou MF, Singer E, Romond MB, Dubreuil L	FEMS Microbiol Lett	10.1111/j.1574-6968.1998.tb13911.x	1998	*
Pathogenicity	Influence of stress conditions on Bacteroides fragilis survival and protein profiles.	Avelar KE, Moraes SR, Pinto LJ, Silva e Souza W das G, Domingues RM, Ferreira MC	Zentralbl Bakteriol		1998	*
Metabolism	CD14-dependent activation of human endothelial cells by Bacteroides fragilis outer membrane.	Sato TT, Kovacich JC, Boyle EM Jr, Haddix TL, Weintraub A, Pohlman TH	J Surg Res	10.1006/jsre.1997.5248	1998	*
Pathogenicity	Anti-anaerobic activity of erythromycin, azithromycin and clarithromycin: effect of pH adjustment of media to compensate for pH shift caused by incubation in CO2.	Ednie LM, Jacobs MR, Appelbaum PC	J Antimicrob Chemother	10.1093/jac/41.3.387	1998	*
Enzymology	Use of polymerase chain reaction fingerprinting to compare clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron from Germany and the United States.	Claros MC, Hunt Gerardo S, Citron DM, Goldstein EJ, Schonian G, Rodloff AC	Clin Infect Dis	10.1086/516200	1997	*
Pathogenicity	Antibacterial activities of tosufloxacin against anaerobic bacteria and the electron micrograph of its bactericidal effects.	Takahata M, Nishino T	Chemotherapy	10.1159/000239551	1997	*
Enzymology	A comparison of the haemagglutinating and enzymic activities of Bacteroides fragilis whole cells and outer membrane vesicles.	Patrick S, McKenna JP, O'Hagan S, Dermott E	Microb Pathog	10.1006/mpat.1996.0018	1996	*
Phylogeny	Bacteroides fragilis strains express multiple capsular polysaccharides.	Pantosti A, Tzianabos AO, Reinap BG, Onderdonk AB, Kasper DL	J Clin Microbiol	10.1128/jcm.31.7.1850-1855.1993	1993	*
Enzymology	The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides.	Tzianabos AO, Pantosti A, Baumann H, Brisson JR, Jennings HJ, Kasper DL	J Biol Chem	S0021-9258(19)37177-7	1992	*
Enzymology	Characterization of restriction endonuclease BfrBI from Bacteroides fragilis strains BE3 and AIP 10006.	Azeddoug H, Reysset G, Sebald M	FEMS Microbiol Lett	10.1016/0378-1097(92)90418-n	1992	*
Pathogenicity	The bactericidal activity and postantibiotic effect of trospectomycin.	Yagi BH, Schaadt RD, Zurenko GE	Diagn Microbiol Infect Dis	10.1016/0732-8893(92)90083-6	1992	*
Phylogeny	Analysis of rRNA restriction fragment length polymorphisms from Bacteroides spp. and Bacteroides fragilis isolates associated with diarrhea in humans and animals.	Smith CJ, Callihan DR	J Clin Microbiol	10.1128/jcm.30.4.806-812.1992	1992	*
Enzymology	Enzyme linked immunosorbent assay & indirect fluorescence assay for rapid diagnosis of Bacteroides fragilis infections.	Ayyagari A, Khanna T, Devi S	Indian J Med Res		1992	*
Enzymology	Experimental maxillary sinusitis induced by Bacteroides fragilis. A bacteriological and histological study in rabbits.	Westrin KM, Norlander T, Stierna P, Carlsoo B, Nord CE	Acta Otolaryngol	10.3109/00016489209100791	1992	*
Phylogeny	Flow cytometric analysis of within-strain variation in polysaccharide expression by Bacteroides fragilis by use of murine monoclonal antibodies.	Lutton DA, Patrick S, Crockard AD, Stewart LD, Larkin MJ, Dermott E, McNeill TA	J Med Microbiol	10.1099/00222615-35-4-229	1991	*
Enzymology	Immunochemical characterization of two surface polysaccharides of Bacteroides fragilis.	Pantosti A, Tzianabos AO, Onderdonk AB, Kasper DL	Infect Immun	10.1128/iai.59.6.2075-2082.1991	1991	*
Metabolism	Formation of glycoprotein degrading enzymes by Bacteroides fragilis.	Macfarlane GT, Gibson GR	FEMS Microbiol Lett	10.1016/0378-1097(91)90567-t	1991	*
Pathogenicity	Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem.	Zabransky RJ, Bayola-Mueller L, Jenkins SG, Pitkin DR, Schreckenberger PC, Celig DM, Spiegel CA	J Clin Microbiol	10.1128/jcm.28.12.2804-2805.1990	1990	*
Enzymology	Protein banding patterns of the outer membrane-enriched fraction of Bacteroides bivius.	Dinsmoor MJ, Ebersole JE, Gibbs RS	J Clin Microbiol	10.1128/jcm.28.3.405-408.1990	1990	*
Metabolism	Influence of pH, nutrient availability, and growth rate on amine production by Bacteroides fragilis and Clostridium perfringens.	Allison C, Macfarlane GT	Appl Environ Microbiol	10.1128/aem.55.11.2894-2898.1989	1989	*
Pathogenicity	Serum levels of antibodies against Actinobacillus actinomycetemcomitans in various forms of human periodontitis.	Schenck K, Porter SR, Tollefsen T, Johansen JR, Scully C	Acta Odontol Scand	10.3109/00016358909007712	1989	*
Enzymology	Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide.	Weintraub A, Zahringer U, Wollenweber HW, Seydel U, Rietschel ET	Eur J Biochem	10.1111/j.1432-1033.1989.tb14945.x	1989	*
Metabolism	Macrolide accumulation by Bacteroides fragilis ATCC 25285.	Muto Y, Bandoh K, Watanabe K, Katoh N, Ueno K	Antimicrob Agents Chemother	10.1128/AAC.33.2.242	1989	*
Pathogenicity	Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.	Zabransky RJ, Bobey DG, Barry AL, Allen SD, Fuchs PC, Gerlach EH, Thornsberry C, Sheikh W, Jones RN	J Clin Microbiol	10.1128/jcm.27.1.190-191.1989	1989	*
Pathogenicity	Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens.	Flaherty JF, Rodondi LC, Guglielmo BJ, Fleishaker JC, Townsend RJ, Gambertoglio JG	Antimicrob Agents Chemother	10.1128/AAC.32.12.1825	1988	*
Phylogeny	Beta-subunit of ATP-synthase: a useful marker for studying the phylogenetic relationship of eubacteria.	Amann R, Ludwig W, Schleifer KH	J Gen Microbiol	10.1099/00221287-134-10-2815	1988	*
Metabolism	Characterization of proteases formed by Bacteroides fragilis.	Gibson SA, Macfarlane GT	J Gen Microbiol	10.1099/00221287-134-8-2231	1988	*
Pathogenicity	European collaborative study of reproducibility of quantitative sensitivity testing of anaerobes.	King A, Phillips I	J Antimicrob Chemother	10.1093/jac/21.4.425	1988	*
Pathogenicity	Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelines.	Barry AL, Jones RN	J Clin Microbiol	10.1128/jcm.26.4.776-777.1988	1988	*
Metabolism	Studies on the proteolytic activity of Bacteroides fragilis.	Gibson SA, Macfarlane GT	J Gen Microbiol	10.1099/00221287-134-1-19	1988	*
Pathogenicity	Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure.	Jones RN, Barry AL, Fuchs PC, Allen SD	Diagn Microbiol Infect Dis	10.1016/0732-8893(87)90154-4	1987	*
Enzymology	Immunochemical characterization of a polysaccharide antigen of Bacteroides fragilis with an IgM monoclonal antibody.	Reid JH, Patrick S, Tabaqchali S	J Gen Microbiol	10.1099/00221287-133-1-171	1987	*
Enzymology	Structural studies of the polysaccharide part of the cell wall lipopolysaccharide from Bacteroides fragilis NCTC 9343.	Weintraub A, Zahringer U, Lindberg AA	Eur J Biochem	10.1111/j.1432-1033.1985.tb09154.x	1985	*
Pathogenicity	Evaluation of broth microdilution susceptibility results for anaerobic organisms by use of a rapid direct colony inoculum.	Mangels JI, Lindberg LH	J Clin Microbiol	10.1128/jcm.21.2.269-272.1985	1985	*
Metabolism	LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.	Williamson SI, Wannemuehler MJ, Jirillo E, Pritchard DG, Michalek SM, McGhee JR	J Immunol		1984	*
Metabolism	LPS regulation of the immune response: Bacteroides endotoxin induces mitogenic, polyclonal, and antibody responses in classical LPS responsive but not C3H/HeJ mice.	Wannemuehler MJ, Michalek SM, Jirillo E, Williamson SI, Hirasawa M, McGhee JR	J Immunol		1984	*
Pathogenicity	Establishment of minimum inhibitory concentrations of cefoperazone for control and reference anaerobic organisms.	Zabransky RJ, Randall E, Sutter VL, Birk RJ, Westenfelder G, Emmerman J, Ghoneim AT	J Clin Microbiol	10.1128/jcm.17.4.711-714.1983	1983	*
Metabolism	In vitro utilization of mucin by Bacteroides fragilis.	Roberton AM, Stanley RA	Appl Environ Microbiol	10.1128/aem.43.2.325-330.1982	1982	*
Enzymology	Precipitating carbohydrate antigens of Bacteroides fragilis NCTC 9343.	Hofstad T	Acta Pathol Microbiol Scand B	10.1111/j.1699-0463.1981.tb00179_89b.x	1981	*
Enzymology	Influence of heme and vitamin B12 on growth and fermentations of Bacteroides species.	Chen M, Wolin MJ	J Bacteriol	10.1128/jb.145.1.466-471.1981	1981	*
Pathogenicity	Cytopathogenic effect caused by Bacteroides fragilis endotoxin.	Sawicka-Grzelak A, Polna I, Meisel-Mikolajczyk F	J Hyg Epidemiol Microbiol Immunol		1980	*
Cultivation	Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.	Sutter VL, Barry AL, Wilkins TD, Zabransky RJ	Antimicrob Agents Chemother	10.1128/AAC.16.4.495	1979	*
Phylogeny	Identification of Bacteroides fragilis by indirect immunofluorescence.	Weintraub A, Lindberg AA, Nord CE	Med Microbiol Immunol	10.1007/BF02120807	1979	*
Metabolism	Factors affecting production of catalase by Bacteroides.	Wilkins TD, Wagner DL, Veltri BJ Jr, Gregory EM	J Clin Microbiol	10.1128/jcm.8.5.553-557.1978	1978	*
Metabolism	Requirement of heme for growth of Bacteroides fragilis.	Sperry JF, Appleman MD, Wilkins TD	Appl Environ Microbiol	10.1128/aem.34.4.386-390.1977	1977	*
Enzymology	Purification and characterization of bile salt hydrolase from Bacteroides fragilis subsp. fragilis.	Stellwag EJ, Hylemon PB	Biochim Biophys Acta	10.1016/0005-2744(76)90068-1	1976	*
Enzymology	Purification of the O antigen of Bacteroides fragilis ss. fragilis NCTC 9343 from phenol-water extracts by gel filtration and chromatography on deae-cellulose and hydroxylapatite.	Hofstad T	Acta Pathol Microbiol Scand B	10.1111/j.1699-0463.1976.tb01930.x	1976	*
Biotechnology	Production of cell-bound antigens by Bacteroides fragilis nctc 9343 in continuous culture.	Dalland E, Hofstad T	Acta Pathol Microbiol Scand B	10.1111/j.1699-0463.1975.tb00068.x	1975	*
Cultivation	Growth of Bacteroides fragilis in continuous culture and in batch cultures at controlled pH.	Dalland E, Hofstad T	Appl Microbiol	10.1128/am.28.5.856-860.1974	1974	*
Pathogenicity	Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model.	Peterson ML, Hovde LB, Wright DH, Brown GH, Hoang AD, Rotschafer JC	Antimicrob Agents Chemother	10.1128/AAC.46.1.203-210.2002	2002	*
Phylogeny	Bacteroides fragilis isolates compared by AP-PCR.	Moraes SR, Goncalves RB, Mouton C, Seldin L, Ferreira MC, Domingues RM	Res Microbiol	10.1016/s0923-2508(99)80050-3	1999	*
Enzymology	Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.	Zabinski RA, Vance-Bryan K, Krinke AJ, Walker KJ, Moody JA, Rotschafer JC	Antimicrob Agents Chemother	10.1128/AAC.37.11.2454	1993	*
Enzymology	Monoclonal antibodies to Bacteroides fragilis lipopolysaccharide.	Linko-Kettunen L, Arstila P, Jalkanen M, Jousimies-Somer H, Lassila O, Lehtonen OP, Weintraub A, Viljanen MK	J Clin Microbiol	10.1128/jcm.20.3.519-524.1984	1984	*
Phylogeny	Use of an immunoperoxidase method for identification of Bacteroides fragilis.	Hsu PC, Minshew BH, Williams BL, Lennard ES	J Clin Microbiol	10.1128/jcm.10.3.285-289.1979	1979	*
Metabolism	Bacteroides fragilis ameliorates Cronobacter malonaticus lipopolysaccharide-induced pathological injury through modulation of the intestinal microbiota.	Ling N, Zhang X, Forsythe S, Zhang D, Shen Y, Zhang J, Ding Y, Wang J, Wu Q, Ye Y	Front Immunol	10.3389/fimmu.2022.931871	2022	*
	Total Synthesis of Zwitterionic Tetrasaccharide Repeating Unit from Bacteroides fragilis ATCC 25285/NCTC 9343 Capsular Polysaccharide PS A1 with Alternating Charges on Adjacent Monosaccharides.	Eradi P, Ghosh S, Andreana PR	Org Lett	10.1021/acs.orglett.8b01829	2018	*
	Safety Evaluation of a Novel Strain of Bacteroides fragilis.	Wang Y, Deng H, Li Z, Tan Y, Han Y, Wang X, Du Z, Liu Y, Yang R, Bai Y, Bi Y, Zhi F	Front Microbiol	10.3389/fmicb.2017.00435	2017	*
	Synthesis of an Aminooxy Derivative of the Tetrasaccharide Repeating Unit of Streptococcus dysgalactiae 2023 Polysaccharide for a PS A1 Conjugate Vaccine.	Ghosh S, Nishat S, Andreana PR	J Org Chem	10.1021/acs.joc.6b00195	2016	*
	Elucidating Structural Features of an Entirely Carbohydrate Cancer Vaccine Construct Employing Circular Dichroism and Fluorescent Labeling.	Trabbic KR, De Silva RA, Andreana PR	Medchemcomm	10.1039/C4MD00038B	2014	*
	Efficient electrotransformation of Bacteroides fragilis.	Ichimura M, Nakayama-Imaohji H, Wakimoto S, Morita H, Hayashi T, Kuwahara T	Appl Environ Microbiol	10.1128/AEM.02420-09	2010	*
	Characterization of beta-lactam-resistant Bacteroides fragilis isolates by use of PCR fingerprinting.	Fang H, Hedberg M, Edlund C, Jarstrand C, Fodor E, Nord CE	Anaerobe	10.1006/anae.1999.0183	1999	*
	Effects of laparoscopic models on anaerobic bacterial growth with bacteroides fragilis in experimentally induced peritonitis.	Sare M, Demirkiran AE, Tastekin N, Durmaz B	J Laparoendosc Adv Surg Tech A	10.1089/109264203766207690	2003	*
	Immunochemical and biological characterization of three capsular polysaccharides from a single Bacteroides fragilis strain.	Kalka-Moll WM, Wang Y, Comstock LE, Gonzalez SE, Tzianabos AO, Kasper DL	Infect Immun	10.1128/IAI.69.4.2339-2344.2001	2001	*
	Formation of mucosal polyps in the nasal and maxillary sinus cavities by infection.	Norlander T, Fukami M, Westrin KM, Stierna P, Carlsoo B	Otolaryngol Head Neck Surg	10.1177/019459989310900322	1993	*
	Nature, type of linkage, quantity, and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains.	Wollenweber HW, Rietschel ET, Hofstad T, Weintraub A, Lindberg AA	J Bacteriol	10.1128/jb.144.3.898-903.1980	1980	*
	Occurrence of free ceramides in Bacteroides fragilis NCTC 9343.	Miyagawa E, Azuma R, Suto T, Yano I	J Biochem	10.1093/oxfordjournals.jbchem.a132528	1979	*
	Ultrastructure of Bacteroides species: Bacteroides asaccharolyticus, Bacteroides fragilis, Bacteroides melaninogenicus subspecies melaninogenicus, and B. melaninogenicus subspecies intermedius.	Woo DD, Holt SC, Leadbetter ER	J Infect Dis	10.1093/infdis/139.5.534	1979	*
	Cross-reactivity of Bacteroides fragilis O antigens.	Hofstad T	Acta Pathol Microbiol Scand B	10.1111/j.1699-0463.1977.tb01668.x	1977	*
	Serum antibody response to Bacteroides fragilis in experimental sinusitis.	Westrin KM, Stierna P, Weintraub A, Palmgren AC, Nord CE	Infection	10.1007/BF01726458	1991	*
	The growth and survival of capsulate and non-capsulate Bacteroides fragilis in vivo and in vitro.	Patrick S, Reid JH, Larkin MJ	J Med Microbiol	10.1099/00222615-17-3-237	1984	*
	Capsular polysaccharides and lipopolysaccharides from two strains of Bacteroides fragilis.	Kasper DL, Lindberg AA, Weintraub A, Onderdonk AB, Lonngren J	Rev Infect Dis	10.1093/clinids/6.supplement_1.s25	1984	*
	Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization.	Kasper DL, Weintraub A, Lindberg AA, Lonngren J	J Bacteriol	10.1128/jb.153.2.991-997.1983	1983	*

References

#979	Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 2151

#20215

Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 )

#20218

Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.: StrainInfo introduces electronic passports for microorganisms.. Syst Appl Microbiol. 37: 42 - 50 2014 ( DOI 10.1016/j.syapm.2013.11.002 , PubMed 24321274 )

#41787 ; Curators of the CIP;
#44796 Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 4856

#66792

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#66794

Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg: BRENDA, the ELIXIR core data resource in 2021: new developments and updates. Nucleic Acids Res. 49: D498 - D508 2020 ( DOI 10.1093/nar/gkaa1025 , PubMed 33211880 )

#67770 Japan Collection of Microorganism (JCM) ; Curators of the JCM;

#68367

Automatically annotated from API 20A .

#68380

Automatically annotated from API rID32A .

#68382

Automatically annotated from API zym .

#69479

João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta .

#69480

Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) .

#69481

Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch: Predictions based on the model GenomeNet Sporulation v. 1 . ( DOI 10.21203/rs.3.rs-2527258/v1 )

#71230

Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.: StrainInfo: A central database for resolving microbial strain identifiers . ( DOI 10.60712/SI-ID389404.1 )

#119445 Collection of Institut Pasteur ; Curators of the CIP; CIP 77.16
* These data were automatically processed and therefore are not curated

Change proposal

You found an error in BacDive? Please tell us about it!

Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.

Search for species Bacteroides fragilis in external resources:
SILVA
BRENDA
PANGAEA
StrainInfo
GBIF

Bacteroides fragilis NCTC 9343 NCTC 9343

Bacteroides fragilis NCTC 9343 NCTC 9343

Change proposal

Change proposal